Informations:
Erreur:
ID
31874
Description
A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00810199
Lien
https://clinicaltrials.gov/show/NCT00810199
Mots-clés
Versions (1)
- 05/10/2018 05/10/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
5 octobre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Rheumatoid Arthritis NCT00810199
Eligibility Rheumatoid Arthritis NCT00810199
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00810199
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Adult | Age
Item
adult patients, ≥ 18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid arthritis moderate Disease activity score das28 | Rheumatoid Arthritis Severe Disease activity score das28
Item
moderate to severe active rheumatoid arthritis (disease activity score (das28) > 4.4);
boolean
C2368567 (UMLS CUI [1,1])
C4481729 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C4481729 (UMLS CUI [2,3])
C4481729 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C4481729 (UMLS CUI [2,3])
Methotrexate Response Inadequate
Item
inadequate response to methotrexate;
boolean
C0025677 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
Methotrexate Dose Stable U/week
Item
on a stable dose of ≥ 15mg/week methotrexate for at least 6 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
Biological agent
Item
prior treatment with a biologic;
boolean
C0005515 (UMLS CUI [1])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis (ra) functional class iv;
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Bacterial Infections | Virus Diseases | Mycoses | Mycobacterial Infections | Communicable Diseases | Recurrent bacterial infection | Recurrent viral infection | Recurrent fungal infections | Recurrent mycobacterial infections | Recurrent infections
Item
known active current or history of recurrent bacterial, viral, fungal, mycobacterial or other infections;
boolean
C0004623 (UMLS CUI [1])
C0042769 (UMLS CUI [2])
C0026946 (UMLS CUI [3])
C0026918 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C1844383 (UMLS CUI [6])
C1837066 (UMLS CUI [7])
C1844384 (UMLS CUI [8])
C4023438 (UMLS CUI [9])
C0239998 (UMLS CUI [10])
C0042769 (UMLS CUI [2])
C0026946 (UMLS CUI [3])
C0026918 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C1844383 (UMLS CUI [6])
C1837066 (UMLS CUI [7])
C1844384 (UMLS CUI [8])
C4023438 (UMLS CUI [9])
C0239998 (UMLS CUI [10])
Malignant Neoplasms
Item
evidence of active malignant disease.
boolean
C0006826 (UMLS CUI [1])